Europe Facial Injectable Market Size, Share & Trends Analysis Report By Product (Collagen & PMMA Microspheres, Hyaluronic Acid), By Application (Facial Line Correction, Face Lift), By End-use (Dermatology Clinics, MedSpa), By Country, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Product
                        1.2.2. End-use
                        1.2.3. Application
                        1.2.4. Country
                        1.2.5. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                        1.4.5.1. Data for primary interviews in Europe
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Product outlook
                        2.2.2. End-use outlook
                        2.2.3. Application outlook
                        2.2.4. Country outlook
                    2.3. Competitive Insights
Chapter 3. Europe Facial Injectable Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Growth in aging population
                            3.2.1.2. Increasing awareness and acceptance of aesthetic treatment
                            3.2.1.3. Technological advancements
                        3.2.2. Market restraint analysis
                            3.2.2.1. High cost
                            3.2.2.2. Regulatory constraints
                    3.3. Europe Facial Injectable Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s Five Forces
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
Chapter 4. Europe Facial Injectable Market: Product Estimates & Trend Analysis
                    4.1. Europe Facial Injectable Market: Product Dashboard
                    4.2. Europe Facial Injectable Market: Product Analysis
                    4.3. Europe Facial Injectable Market: Size & Forecasts and Trend Analyses, 2018 to 2030
                    4.4. Europe Facial Injectable Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
                        4.4.1. Collagen & PMMA Microspheres
                            4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.2. Botulinum Toxin Type A
                            4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.3. Hyaluronic Acid
                            4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.4. Calcium Hydroxylapatite (CaHA)
                            4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.5. Poly-L-lactic Acid (PLLA)
                            4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.6. Others
                            4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Europe Facial Injectable Market: End-use Estimates & Trend Analysis
                    5.1. Europe Facial Injectable Market: End-use Dashboard
                    5.2. Europe Facial Injectable Market: End-use Analysis
                    5.3. Europe Facial Injectable Market: Size & Forecasts and Trend Analyses, 2018 to 2030
                        5.3.1. MedSpa
                            5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.3.2. Dermatology Clinics
                            5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.3.3. Hospitals
                            5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Europe Facial Injectable Market: Application Estimates & Trend Analysis
                    6.1. Europe Facial Injectable Market: Application Dashboard
                    6.2. Europe Facial Injectable Market: Application Analysis
                    6.3. Europe Facial Injectable Market: Size & Forecasts and Trend Analyses, 2018 to 2030
                        6.3.1. Facial Line Correction
                            6.3.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
                        6.3.2. Lip Augmentation
                            6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        6.3.3. Face Lift
                            6.3.3.1. Market estimates and forecasts 2018 to 2030 (USD million)
                        6.3.4. Acne Scar Treatment
                            6.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        6.3.5. Facial Line Correction
                            6.3.5.1. Market estimates and forecasts 2018 to 2030 (USD million)
                        6.3.6. Lipoatrophy Treatment
                            6.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        6.3.7. Others
                            6.3.7.1. Market estimates and forecasts 2018 to 2030 (USD million)
Chapter 7. Europe Facial Injectable Market: Country Estimates & Trend Analysis
                    7.1. Europe Facial Injectable Market: Country Dashboard
                    7.2. Europe Facial Injectable Market: Country Analysis
                    7.3. Europe Facial Injectable Market: Size & Forecasts and Trend Analyses, 2018 to 2030
                        7.3.1. UK
                            7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        7.3.2. Germany
                            7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        7.3.3. France
                            7.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        7.3.4. Italy
                            7.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        7.3.5. Spain
                            7.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        7.3.6. Norway
                            7.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        7.3.7. Sweden
                            7.3.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        7.3.8. Denmark
                            7.3.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Recent Developments & Impact Analysis, By Key Market Participants
                    8.2. Company/Competition Categorization
                    8.3. Vendor Landscape
                        8.3.1. List of key distributors and channel partners
                        8.3.2. Key customers
                        8.3.3. Key company market share analysis, 2023
                        8.3.4. Ispen
                            8.3.4.1. Company overview
                            8.3.4.2. Financial performance
                            8.3.4.3. Product benchmarking
                            8.3.4.4. Strategic initiatives
                        8.3.5. Allergan Aesthetics (AbbVie)
                            8.3.5.1. Company overview
                            8.3.5.2. Financial performance
                            8.3.5.3. Product benchmarking
                            8.3.5.4. Strategic initiatives
                        8.3.6. Medytox Inc.
                            8.3.6.1. Company overview
                            8.3.6.2. Financial performance
                            8.3.6.3. Product benchmarking
                            8.3.6.4. Strategic initiatives
                        8.3.7. Merz GmbH and Co. KGaA
                            8.3.7.1. Company overview
                            8.3.7.2. Financial performance
                            8.3.7.3. Product benchmarking
                            8.3.7.4. Strategic initiatives
                        8.3.8. Revance Therapeutics, Inc.
                            8.3.8.1. Company overview
                            8.3.8.2. Financial performance
                            8.3.8.3. Product benchmarking
                            8.3.8.4. Strategic initiatives
                        8.3.9. Galderma
                            8.3.9.1. Company overview
                            8.3.9.2. Financial performance
                            8.3.9.3. Product benchmarking
                            8.3.9.4. Strategic initiatives
                        8.3.10. Sinclair Pharma
                            8.3.10.1. Company overview
                            8.3.10.2. Financial performance
                            8.3.10.3. Product benchmarking
                            8.3.10.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 Europe facial injectable market, by product, 2018 - 2030 (USD Million)
Table 3 Europe facial injectable market, by end-use, 2018 - 2030 (USD Million)
Table 4 Europe facial injectable market, by application, 2018 - 2030 (USD Million)
Table 5 Europe facial injectable market, by country, 2018 - 2030 (USD Million)
Table 6 Germany facial injectable market, by product, 2018 - 2030 (USD Million)
Table 7 Germany facial injectable market, by end-use, 2018 - 2030 (USD Million)
Table 8 Germany facial injectable market, by application, 2018 - 2030 (USD Million)
Table 9 UK facial injectable market, by product, 2018 - 2030 (USD Million)
Table 10 UK facial injectable market, by end-use, 2018 - 2030 (USD Million)
Table 11 UK facial injectable market, by application, 2018 - 2030 (USD Million)
Table 12 France facial injectable market, by product, 2018 - 2030 (USD Million)
Table 13 France facial injectable market, by end-use, 2018 - 2030 (USD Million)
Table 14 France facial injectable market, by application, 2018 - 2030 (USD Million)
Table 15 Italy facial injectable market, by product, 2018 - 2030 (USD Million)
Table 16 Italy facial injectable market, by end-use, 2018 - 2030 (USD Million)
Table 17 Italy facial injectable market, by application, 2018 - 2030 (USD Million)
Table 18 Spain facial injectable market, by product, 2018 - 2030 (USD Million)
Table 19 Spain facial injectable market, by end-use, 2018 - 2030 (USD Million)
Table 20 Spain facial injectable market, by application, 2018 - 2030 (USD Million)
Table 21 Denmark facial injectable market, by product, 2018 - 2030 (USD Million)
Table 22 Denmark facial injectable market, by end-use, 2018 - 2030 (USD Million)
Table 23 Denmark facial injectable market, by application, 2018 - 2030 (USD Million)
Table 24 Sweden facial injectable market, by product, 2018 - 2030 (USD Million)
Table 25 Sweden facial injectable market, by end-use, 2018 - 2030 (USD Million)
Table 26 Sweden facial injectable market, by application, 2018 - 2030 (USD Million)
Table 27 Norway facial injectable market, by product, 2018 - 2030 (USD Million)
Table 28 Norway facial injectable market, by end-use, 2018 - 2030 (USD Million)
Table 29 Norway facial injectable market, by application, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Europe facial injectable market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 End-use and end-use segment snapshot
Fig. 10 Sales channel and age segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Market dynamics
Fig. 13 Porter’s Five Forces analysis
Fig. 14 PESTLE analysis
Fig. 15 Europe facial injectable market: Product outlook and key takeaways
Fig. 16 Europe facial injectable market: Product movement analysis
Fig. 17 Collagen & PMMA Microspheres market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Botulinum Toxin Type A market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Hyaluronic acid market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 CaHA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 PLLA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Europe facial injectable market: End-use outlook and key takeaways
Fig. 24 Europe facial injectable market: End-use movement analysis
Fig. 25 MedSpa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Dermatology Clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Europe facial injectable market: Application outlook and key takeaways
Fig. 29 Europe facial injectable market: Application movement analysis
Fig. 30 Facial line correction market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Lip augmentation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Facelift market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Acne scar treatment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Lipoatrophy treatment correction market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Europe facial injectable market: Country outlook and key takeaways
Fig. 37 Europe facial injectable market: Country movement analysis
Fig. 38 UK market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Germany market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 France market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Italy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Spain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Norway market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Company market share analysis, 2023
Fig. 47 Strategic Framework